Literature DB >> 22439080

Biochemical markers for prediction of preclampsia: review of the literature.

Santo Monte1.   

Abstract

Preeclampsia (PE) is one of the most common diseases worldwide, complicating ~5% of all pregnancies.Although no major progress has been achieved in the treatment of PE, our ability to identify women at highrisk has increased considerably during the past decade.The early identification of patients with an increased risk for preeclampsia is therefore one of the most important goals in obstetrics. Today, several markers may offer the potential to be used, most likely in a combinatory analysis, as predictors or diagnostic tools. We present here the current knowledge on the biology of preeclampsia and review several biochemical markers which may be used to monitor preeclampsia in a future, that, we hope, is not to distant from today.

Entities:  

Keywords:  ADAM12; P-selectin; PAPP-A.; PP-13; PTX3; early diagnosis; effDNA; flt-1; hypertension; preeclampsia; sEng

Year:  2011        PMID: 22439080      PMCID: PMC3279168     

Source DB:  PubMed          Journal:  J Prenat Med        ISSN: 1971-3282


  104 in total

1.  Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction.

Authors:  Florence Bretelle; Florence Sabatier; Dominique Desprez; Laurence Camoin; Leila Grunebaum; Valérie Combes; Claude D'Ercole; Françoise Dignat-George
Journal:  Thromb Haemost       Date:  2003-03       Impact factor: 5.249

2.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

3.  Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia.

Authors:  Jennie Laigaard; Tina Sørensen; Sophie Placing; Peter Holck; Camilla Fröhlich; Karen R Wøjdemann; Karin Sundberg; Anne-Cathrine Shalmi; Ann Tabor; Bent Nørgaard-Pedersen; Bent Ottesen; Michael Christiansen; Ulla M Wewer
Journal:  Obstet Gynecol       Date:  2005-07       Impact factor: 7.661

4.  Characterization of the enzymatic specificity of the IGF-dependent insulin-like growth factor binding protein-4 (IGFBP-4) protease.

Authors:  D Chelius; C A Conover; M A Baldwin; E M Spencer
Journal:  Growth Horm IGF Res       Date:  2000-12       Impact factor: 2.372

5.  Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation.

Authors:  W Heyl; S Handt; F Reister; J Gehlen; W Schröder; C Mittermayer; W Rath
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-09       Impact factor: 2.435

6.  Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.

Authors:  Kevin Spencer; Nicholas J Cowans; Kypros H Nicolaides
Journal:  Prenat Diagn       Date:  2008-01       Impact factor: 3.050

7.  Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Francesca Gotsch; Jimmy Espinoza; Jyh Kae Nien; Luis Goncalves; Samuel Edwin; Yeon Mee Kim; Offer Erez; Juan Pedro Kusanovic; Beth L Pineles; Zoltan Papp; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01

8.  Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia.

Authors:  María E Chavarría; Lina Lara-González; Yolanda García-Paleta; Víctor S Vital-Reyes; Alejandro Reyes
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2007-08-13       Impact factor: 2.435

9.  The long pentraxin PTX3 in human endometrium: regulation by steroids and trophoblast products.

Authors:  Roxana M Popovici; Miriam S Krause; Julia Jauckus; Ariane Germeyer; Ilma S Brum; Cecilia Garlanda; Thomas Strowitzki; Michael von Wolff
Journal:  Endocrinology       Date:  2007-11-29       Impact factor: 4.736

10.  Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.

Authors:  Anna-Karin Wikström; Anders Larsson; Ulf J Eriksson; Peppi Nash; Solveig Nordén-Lindeberg; Matts Olovsson
Journal:  Obstet Gynecol       Date:  2007-06       Impact factor: 7.661

View more
  7 in total

1.  Predictive performance of first trimester serum galectin-13/PP-13 in preeclampsia screening: A systematic review and meta-analysis.

Authors:  Ingrid-Andrada Vasilache; Alexandru Carauleanu; Demetra Socolov; Roxana Matasariu; Ioana Pavaleanu; Dragos Nemescu
Journal:  Exp Ther Med       Date:  2022-04-05       Impact factor: 2.751

Review 2.  A Data-Driven Review of the Genetic Factors of Pregnancy Complications.

Authors:  Yury A Barbitoff; Alexander A Tsarev; Elena S Vashukova; Evgeniia M Maksiutenko; Liudmila V Kovalenko; Larisa D Belotserkovtseva; Andrey S Glotov
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

3.  Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes.

Authors:  Lorena M Amaral; Valeria C Sandrim; Matthew E Kutcher; Frank T Spradley; Ricardo C Cavalli; Jose E Tanus-Santos; Ana C Palei
Journal:  Int J Mol Sci       Date:  2021-01-08       Impact factor: 6.208

4.  The relationship between maternal vitamin D deficiency and glycolipid metabolism and adverse pregnancy outcome.

Authors:  Hai-Ying Chen; Hong-Ping Zhang; Jie Yang; Zhi-Qiong Huang; Hai-Xia Xu; Jiang Jin; Kai Xu; Yu Tong; Qian-Qian Dong; Jian-Qiong Zheng
Journal:  Clin Endocrinol (Oxf)       Date:  2020-09-02       Impact factor: 3.478

Review 5.  The complement cascade and renal disease.

Authors:  Katarzyna Kościelska-Kasprzak; Dorota Bartoszek; Marta Myszka; Marcelina Zabińska; Marian Klinger
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-09-13       Impact factor: 4.291

6.  Development of a new methylation-based fetal fraction estimation assay using multiplex ddPCR.

Authors:  Marios Ioannides; Achilleas Achilleos; Skevi Kyriakou; Elena Kypri; Charalambos Loizides; Kyriakos Tsangaras; Louiza Constantinou; George Koumbaris; Philippos C Patsalis
Journal:  Mol Genet Genomic Med       Date:  2019-12-10       Impact factor: 2.183

7.  Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study.

Authors:  Evelyn A Huhn; Ina Hoffmann; Begoña Martinez De Tejada; Soeren Lange; Kylie M Sage; Charles T Roberts; Michael G Gravett; Srinivasa R Nagalla; Olav Lapaire
Journal:  BMC Pregnancy Childbirth       Date:  2020-02-24       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.